Home » News » Awards & Advancement » Omthera names Lloyd VP regulatory affairs

Omthera names Lloyd VP regulatory affairs

Monday, August 1, 2011

Omthera Pharmaceuticals reports that Ramona M. Lloyd has joined the company as vice president regulatory affairs, effective immediately.  In this newly created position, Dr. Lloyd will be responsible for the management of all regulatory activities, including regulatory strategy and interactions with the FDA.

Dr. Lloyd previously served as vice president, regulatory affairs for Ethicon, a Johnson & Johnson company. Dr. Lloyd also held positions at Imclone Systems, a wholly-owned subsidiary of Eli Lilly, including, interim senior vice president, global regulatory affairs and drug safety as well as vice president, regulatory affairs-late development. 

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!